Author: Craig Boerner
Feb. 21, 2024—Vanderbilt Urology’s newly renovated TVC clinic features a slightly larger and much more efficient space, nitrous oxide in the procedure rooms, a new high definition C-Arm X-ray machine and a urodynamics unit, thereby expanding the range of procedures that can be performed in clinic without having to go to the operating room.
Feb. 6, 2024—A familiar voice will be speaking in an advertisement created by Vanderbilt University Medical Center that is scheduled to run this Sunday during the big game in two 30-second spots
Jan. 29, 2024—Joseph Smith Jr., MD, recent decision to step back from clinical practice is allowing him to focus entirely on global surgery efforts departmentally with faculty, fellows and residents to provide opportunities he believes are a key part of infusing humanitarian intent into their training.
Jan. 24, 2024—A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.
Jan. 17, 2024—The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.
Dec. 18, 2023—The Society of Women in Urologic Oncology (WUO) has named Vanderbilt's Amy Luckenbaugh, MD, to chair its Executive Board until Nov. 2025.
Oct. 24, 2023—Researchers at Vanderbilt are considering participation in an international study to examine if a blood-clotting medication given to adults with major bleeding or in need of urgent surgery or an invasive procedure can improve survival.
Oct. 5, 2023—African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.
Aug. 7, 2023—Vanderbilt research shows that most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care.
Jul. 17, 2023—Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a simple procedure known as “direct oral challenge” as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.